Dr Stephen Robinson joined DNDi in May 2012 with responsibility for all Pharmaceutical Development (CMC) activities.
Dr Robinson has over twenty years’ pharmaceutical industry experience gained in R&D, manufacturing and CMC project/portfolio management roles. Prior to joining DNDi, he held several senior positions in Pfizer Worldwide R&D, including Director in Analytical R&D and Research Portfolio Director in Pharmaceutical Sciences. During this time he gained extensive experience of pharmaceutical development, quality and regulatory requirements, as well as managing international CMC teams to deliver three major projects.
Stephen has a PhD in physical organic/peptide chemistry from the Open University (1993) and an MBA from the University of Kent (2011).
He is a Chartered Chemist and Fellow of the Royal Society of Chemistry in the UK.